{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T20:07:30Z","timestamp":1767730050506,"version":"build-2238731810"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Xuzhou Health Commission Project","award":["XWKYHT20200068"],"award-info":[{"award-number":["XWKYHT20200068"]}]},{"name":"Xuzhou Health Commission Project","award":["XWKYHT20230015"],"award-info":[{"award-number":["XWKYHT20230015"]}]},{"name":"Xuzhou Science and Technology Bureau Project","award":["KC23231"],"award-info":[{"award-number":["KC23231"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-20615-4","type":"journal-article","created":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T09:27:10Z","timestamp":1761038830000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Single-cell and bulk transcriptomics uncovers PRKD2-driven tumor stemness and progression in multiple myeloma"],"prefix":"10.1038","volume":"15","author":[{"given":"Guihua","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shengya","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chong","family":"Geng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yueyue","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinge","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faan","family":"Miao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huanxin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunxin","family":"Kong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rongke","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaige","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaqian","family":"Qi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,21]]},"reference":[{"issue":"6","key":"20615_CR1","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1053\/j.seminoncol.2016.11.004","volume":"43","author":"D Kazandjian","year":"2016","unstructured":"Kazandjian, D. Multiple myeloma epidemiology and survival: A unique malignancy. Semin. Oncol. 43 (6), 676\u2013681 (2016).","journal-title":"Semin. Oncol."},{"issue":"5","key":"20615_CR2","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1046\/j.1365-2141.2003.04355.x","volume":"121","author":"Criteria for the classification of","year":"2003","unstructured":"Criteria for the classification of. Monoclonal gammopathies, multiple myeloma and related disorders: a report of the international myeloma working group. Br. J. Haematol. 121 (5), 749\u2013757 (2003).","journal-title":"Br. J. Haematol."},{"issue":"9686","key":"20615_CR3","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/S0140-6736(09)60221-X","volume":"374","author":"MS Raab","year":"2009","unstructured":"Raab, M. S., Podar, K., Breitkreutz, I., Richardson, P. G. & Anderson, K. C. Multiple myeloma. Lancet 374 (9686), 324\u2013339 (2009).","journal-title":"Lancet"},{"issue":"6","key":"20615_CR4","doi-asserted-by":"publisher","first-page":"2962","DOI":"10.1182\/blood-2007-10-078022","volume":"111","author":"RA Kyle","year":"2008","unstructured":"Kyle, R. A. & Rajkumar, S. V. Multiple myeloma. Blood. 111 (6), 2962\u20132972 (2008).","journal-title":"Blood"},{"issue":"1","key":"20615_CR5","first-page":"Cd009768","volume":"1","author":"SA Fisher","year":"2019","unstructured":"Fisher, S. A. et al. Mesenchymal stromal cells as treatment or prophylaxis for acute or chronic graft-versus-host disease in Haematopoietic stem cell transplant (HSCT) recipients with a haematological condition. Cochrane Database Syst. Rev. 1 (1), Cd009768 (2019).","journal-title":"Cochrane Database Syst. Rev."},{"issue":"11","key":"20615_CR6","first-page":"Cd010983","volume":"2015","author":"LJ Estcourt","year":"2015","unstructured":"Estcourt, L. J. et al. Comparison of different platelet count thresholds to guide administration of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation. Cochrane Database Syst. Rev. 2015 (11), Cd010983 (2015).","journal-title":"Cochrane Database Syst. Rev."},{"issue":"19","key":"20615_CR7","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1056\/NEJMoa022340","volume":"348","author":"JA Child","year":"2003","unstructured":"Child, J. A. et al. High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma. N. Engl. J. Med. 348 (19), 1875\u20131883 (2003).","journal-title":"N. Engl. J. Med."},{"issue":"15","key":"20615_CR8","doi-asserted-by":"publisher","first-page":"3412","DOI":"10.1200\/JCO.2005.04.242","volume":"23","author":"PR Greipp","year":"2005","unstructured":"Greipp, P. R. et al. International staging system for multiple myeloma. J. Clin. Oncol. 23 (15), 3412\u20133420 (2005).","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"20615_CR9","doi-asserted-by":"publisher","first-page":"2322","DOI":"10.3390\/curroncol30020179","volume":"30","author":"P Bhatt","year":"2023","unstructured":"Bhatt, P., Kloock, C. & Comenzo, R. Relapsed\/Refractory multiple myeloma: A review of available therapies and clinical scenarios encountered in myeloma relapse. Curr. Oncol. 30 (2), 2322\u20132347 (2023).","journal-title":"Curr. Oncol."},{"key":"20615_CR10","doi-asserted-by":"crossref","unstructured":"Hideshima, T. & Anderson, K. C. Signaling pathway mediating myeloma cell growth and survival. Cancers (Basel). ;13(2). (2021).","DOI":"10.3390\/cancers13020216"},{"issue":"3","key":"20615_CR11","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1182\/blood-2016-08-731885","volume":"129","author":"J Rosenblatt","year":"2017","unstructured":"Rosenblatt, J. & Avigan, D. Targeting the PD-1\/PD-L1 axis in multiple myeloma: a dream or a reality? Blood. 129 (3), 275\u2013279 (2017).","journal-title":"Blood"},{"issue":"5","key":"20615_CR12","doi-asserted-by":"publisher","first-page":"3310","DOI":"10.1074\/jbc.M008719200","volume":"276","author":"S Sturany","year":"2001","unstructured":"Sturany, S. et al. Molecular cloning and characterization of the human protein kinase D2. A novel member of the protein kinase D family of Serine threonine kinases. J. Biol. Chem. 276 (5), 3310\u20133318 (2001).","journal-title":"J. Biol. Chem."},{"issue":"2","key":"20615_CR13","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1002\/cam4.1938","volume":"8","author":"Y Liu","year":"2019","unstructured":"Liu, Y. et al. Oncogenic functions of protein kinase D2 and D3 in regulating multiple cancer-related pathways in breast cancer. Cancer Med. 8 (2), 729\u2013741 (2019).","journal-title":"Cancer Med."},{"issue":"5","key":"20615_CR14","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.ajpath.2023.01.004","volume":"193","author":"A Roy","year":"2023","unstructured":"Roy, A. et al. Protein kinase D2 and D3 promote prostate cancer cell bone metastasis by positively regulating Runx2 in a MEK\/ERK1\/2-Dependent manner. Am. J. Pathol. 193 (5), 624\u2013637 (2023).","journal-title":"Am. J. Pathol."},{"issue":"3","key":"20615_CR15","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1091\/mbc.e13-06-0334","volume":"25","author":"C Wille","year":"2014","unstructured":"Wille, C. et al. Protein kinase D2 induces invasion of pancreatic cancer cells by regulating matrix metalloproteinases. Mol. Biol. Cell. 25 (3), 324\u2013336 (2014).","journal-title":"Mol. Biol. Cell."},{"issue":"2","key":"20615_CR16","doi-asserted-by":"publisher","first-page":"e981444","DOI":"10.4161\/23723556.2014.981444","volume":"2","author":"N Azoitei","year":"2015","unstructured":"Azoitei, N., Fr\u00f6hling, S., Scholl, C. & Seufferlein, T. PRKD2: A two-pronged kinase crucial for the tumor-supporting activity of HSP90. Mol. Cell. Oncol. 2 (2), e981444 (2015).","journal-title":"Mol. Cell. Oncol."},{"key":"20615_CR17","doi-asserted-by":"crossref","unstructured":"Misawa, T. et al. Mutual inhibition between Prkd2 and Bcl6 controls T follicular helper cell differentiation. Sci. Immunol. ;5(43). (2020).","DOI":"10.1126\/sciimmunol.aaz0085"},{"key":"20615_CR18","doi-asserted-by":"publisher","first-page":"745873","DOI":"10.3389\/fimmu.2021.745873","volume":"12","author":"D Michaud","year":"2021","unstructured":"Michaud, D., Mirlekar, B., Steward, C., Bishop, G. & Pylayeva-Gupta, Y. B cell receptor signaling and protein kinase D2 support regulatory B cell function in pancreatic cancer. Front. Immunol. 12, 745873 (2021).","journal-title":"Front. Immunol."},{"issue":"2","key":"20615_CR19","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.cell.2018.03.034","volume":"173","author":"TM Malta","year":"2018","unstructured":"Malta, T. M. et al. Machine learning identifies stemness features associated with oncogenic dedifferentiation. Cell 173 (2), 338\u2013354 (2018). e15.","journal-title":"Cell"},{"issue":"1","key":"20615_CR20","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28 (1), 27\u201330 (2000).","journal-title":"Nucleic Acids Res."},{"issue":"11","key":"20615_CR21","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1002\/pro.3715","volume":"28","author":"M Kanehisa","year":"2019","unstructured":"Kanehisa, M. Toward Understanding the origin and evolution of cellular organisms. Protein Sci. 28 (11), 1947\u20131951 (2019).","journal-title":"Protein Sci."},{"issue":"D1","key":"20615_CR22","doi-asserted-by":"publisher","first-page":"D672","DOI":"10.1093\/nar\/gkae909","volume":"53","author":"M Kanehisa","year":"2025","unstructured":"Kanehisa, M., Furumichi, M., Sato, Y., Matsuura, Y. & Ishiguro-Watanabe, M. KEGG: biological systems database as a model of the real world. Nucleic Acids Res. 53 (D1), D672\u2013D7 (2025).","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"20615_CR23","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3349\/ymj.2007.48.1.11","volume":"48","author":"SY Choo","year":"2007","unstructured":"Choo, S. Y. The HLA system: genetics, immunology, clinical testing, and clinical implications. Yonsei Med. J. 48 (1), 11\u201323 (2007).","journal-title":"Yonsei Med. J."},{"key":"20615_CR24","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1186\/1479-5876-11-247","volume":"11","author":"M Marchesi","year":"2013","unstructured":"Marchesi, M. et al. HLA-dependent tumour development: a role for tumour associate macrophages? J. Transl. Med. 11, 247 (2013).","journal-title":"J. Transl. Med."},{"key":"20615_CR25","doi-asserted-by":"publisher","first-page":"D960","DOI":"10.2741\/Gruen","volume":"6","author":"JR Gruen","year":"2001","unstructured":"Gruen, J. R. & Weissman, S. M. Human MHC class III and IV genes and disease associations. Front. Biosci. 6, D960\u2013D972 (2001).","journal-title":"Front. Biosci."},{"key":"20615_CR26","doi-asserted-by":"crossref","unstructured":"Hirayama, D., Iida, T. & Nakase, H. The phagocytic function of Macrophage-Enforcing innate immunity and tissue homeostasis. Int. J. Mol. Sci. 19(1). (2017).","DOI":"10.3390\/ijms19010092"},{"issue":"1","key":"20615_CR27","doi-asserted-by":"publisher","first-page":"e8808","DOI":"10.1371\/journal.pone.0008808","volume":"5","author":"R Frei","year":"2010","unstructured":"Frei, R. et al. MHC class II molecules enhance Toll-like receptor mediated innate immune responses. PLoS One. 5 (1), e8808 (2010).","journal-title":"PLoS One"},{"issue":"3","key":"20615_CR28","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.aller.2017.04.006","volume":"46","author":"S Farrokhi","year":"2018","unstructured":"Farrokhi, S. et al. MHC class II deficiency: report of a novel mutation and special review. Allergol. Immunopathol. (Madr). 46 (3), 263\u2013275 (2018).","journal-title":"Allergol. Immunopathol. (Madr)"},{"issue":"3","key":"20615_CR29","first-page":"727","volume":"10","author":"Y Han","year":"2020","unstructured":"Han, Y., Liu, D. & Li, L. PD-1\/PD-L1 pathway: current researches in cancer. Am. J. Cancer Res. 10 (3), 727\u2013742 (2020).","journal-title":"Am. J. Cancer Res."},{"issue":"1","key":"20615_CR30","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s40425-018-0316-z","volume":"6","author":"J Gong","year":"2018","unstructured":"Gong, J., Chehrazi-Raffle, A., Reddi, S. & Salgia, R. Development of PD-1 and PD-L1 inhibitors as a form of cancer immunotherapy: a comprehensive review of registration trials and future considerations. J. Immunother. Cancer. 6 (1), 8 (2018).","journal-title":"J. Immunother. Cancer"},{"key":"20615_CR31","doi-asserted-by":"publisher","first-page":"731798","DOI":"10.3389\/fphar.2021.731798","volume":"12","author":"J Liu","year":"2021","unstructured":"Liu, J. et al. PD-1\/PD-L1 checkpoint inhibitors in tumor immunotherapy. Front. Pharmacol. 12, 731798 (2021).","journal-title":"Front. Pharmacol."},{"issue":"5","key":"20615_CR32","doi-asserted-by":"publisher","first-page":"3044","DOI":"10.3390\/curroncol29050247","volume":"29","author":"Y Shiravand","year":"2022","unstructured":"Shiravand, Y. et al. Immune checkpoint inhibitors in cancer therapy. Curr. Oncol. 29 (5), 3044\u20133060 (2022).","journal-title":"Curr. Oncol."},{"key":"20615_CR33","doi-asserted-by":"publisher","first-page":"2801","DOI":"10.2147\/DDDT.S109640","volume":"11","author":"A Bellesoeur","year":"2017","unstructured":"Bellesoeur, A., Carton, E., Alexandre, J., Goldwasser, F. & Huillard, O. Axitinib in the treatment of renal cell carcinoma: design, development, and place in therapy. Drug Des. Dev.Ther. 11, 2801\u20132811 (2017).","journal-title":"Drug Des. Dev. Ther."},{"issue":"5","key":"20615_CR34","first-page":"307","volume":"10","author":"C Carmichael","year":"2012","unstructured":"Carmichael, C., Lau, C., Josephson, D. Y. & Pal, S. K. Comprehensive overview of axitinib development in solid malignancies: focus on metastatic renal cell carcinoma. Clin. Adv. Hematol. Oncol. 10 (5), 307\u2013314 (2012).","journal-title":"Clin. Adv. Hematol. Oncol."},{"issue":"3","key":"20615_CR35","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.mri.2006.09.041","volume":"25","author":"LJ Wilmes","year":"2007","unstructured":"Wilmes, L. J. et al. AG-013736, a novel inhibitor of VEGF receptor tyrosine kinases, inhibits breast cancer growth and decreases vascular permeability as detected by dynamic contrast-enhanced magnetic resonance imaging. Magn. Reson. Imaging. 25 (3), 319\u2013327 (2007).","journal-title":"Magn. Reson. Imaging"}],"updated-by":[{"DOI":"10.1038\/s41598-025-28728-6","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000}}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-20615-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-20615-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-20615-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T08:33:57Z","timestamp":1764146037000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-20615-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,21]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["20615"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-20615-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,21]]},"assertion":[{"value":"21 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2025","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41598-025-28728-6","URL":"https:\/\/doi.org\/10.1038\/s41598-025-28728-6","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was conducted in accordance with the principles set forth in the Declaration of Helsinki and was approved by the Ethics Committee of Soochow University. Written informed consent was obtained from all participating patients (or their legal guardians), ensuring their voluntary participation and understanding of the research objectives.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human ethics and consent to participate"}},{"value":"All authors provided their consent for publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"36723"}}